ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Sleep Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,125Medicare Part D Prescriptions Filled, Including Refills
$236K Total Retail Price of All Prescriptions
405 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category
AMLODIPINE BESYLATE 223 188 61
OMEPRAZOLE 213 183 61
LISINOPRIL 195 130 54
LOSARTAN POTASSIUM 184 166 50
SIMVASTATIN 172 139 50
CLOPIDOGREL 154 132 38
METOPROLOL TARTRATE 146 131 40
POTASSIUM CHLORIDE 134 114 34
FUROSEMIDE 134 120 41
ZOLPIDEM TARTRATE 124 79 36
ATORVASTATIN CALCIUM 123 87 28
PRAVASTATIN SODIUM 121 90 36
METOPROLOL SUCCINATE 119 100 28
GABAPENTIN 106 86 35
LEVOTHYROXINE SODIUM 90 72 29
GLIMEPIRIDE 86 81* 27
CARVEDILOL 86 81* 27
NEXIUM 74 52 24
TRAZODONE HCL 72 49 19
LOVASTATIN 66 53 16
HYDRALAZINE HCL 65 60* 14
TRAMADOL HCL 64 59* 21
ROPINIROLE HCL 62 45 16
METFORMIN HCL 60 47 16
FLUTICASONE PROPIONATE 58 41 16
METFORMIN HCL ER 58 53* 23
LOSARTAN-HYDROCHLOROTHIAZIDE 55 50* 14
WARFARIN SODIUM 53 41 21
ATENOLOL 51 51 18
MONTELUKAST SODIUM 51 46* 11
RAMIPRIL 51 46* 13
CRESTOR 50 45* 19
PROAIR HFA 50 45* 16
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.